X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

ANTX

Closed

An2 Therapeutics Inc

1.05
-0.01 (-0.94%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.06
Day's Range: 1.05 - 1.07
Send
When Written:
 
9.87
AN2 Therapeutics Inc is a biopharmaceutical company that focuses on developing novel therapies for patients suffering from rare diseases. The company's mission is to improve the lives of patients with rare diseases by developing innovative treatments that target the underlying cause of their conditions. AN2 Therapeutics Inc is headquartered in California, USA, and was founded in 2020. The company's pipeline includes several drug candidates that are in preclinical development for the treatment of rare genetic disorders. AN2 Therapeutics Inc is backed by leading investors in the biotech industry, including Novo Holdings, RA Capital Management, and Samsara BioCapital.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X